Decoding the evolutionary secrets of bats
Paratus Sciences is a biopharmaceutical company that decodes evolutionary biology to discover first-in-class medicines for serious diseases. The company integrates evolutionary insights from species like bats, AI-powered discovery, and multi-omic data to identify novel drug targets, with its lead program PS-1001—a pan-inflammasome inhibitor—advancing toward first-in-human studies in cardiometabolic and inflammatory diseases. It is headquartered in Boston with research operations in Singapore.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJul 2025
Feb 2023
Create a free account to see which investors have funded this company.
Create Free AccountAI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
BridgeBio makes targeted treatments for genetic diseases.
